US$ 29.36
found semaglutide A new clinical trial supported by the National Institutes of Health (NIH) that a medication commonly used for weight loss, such as semaglutide, may also help reduce heavy drinking in individuals Semaglutide | ReadyRx
Description
Learn more: To view or add a comment, sign in FDA is intensifying scrutiny of online claims for compounded GLP-1 drugs

Others require more experimentation

Marked improvement in HbA1c was seen along with even more weight loss among participants with BMI 35 kg/m2

But the FDA has restricted the mass compounding of GLP-1s for safety and regulatory concerns

Excess gas may be linked to stomach problems like GERD (gastroesophageal reflux disease) and IBS (irritable bowel syndrome)
